Drug intelligence / Profile preview

potassium phosphate dibasic + potassium phosphate monobasic

Development stage
Approved
Lead developer
CMP Development
Modality
Small Molecules
Administration
Intravenous
01

Overview

Potassium phosphate dibasic + potassium phosphate monobasic is an approved small molecule electrolyte replenisher used as a phosphorus replacement therapy. The product consists of two inorganic salts, monobasic potassium phosphate (KH2PO4) and dibasic potassium phosphate (K2HPO4), which provide essential phosphorus and potassium ions. It is primarily indicated for the treatment of hypophosphatemia in adults and pediatric patients weighing 40 kg or more when oral or enteral replacement is not possible or sufficient. Phosphorus is critical for bone metabolism, energy production via ATP, and acid-base balance, while potassium is the major intracellular cation required for nerve conduction and muscle contraction. The drug is administered as an intravenous injection and must be diluted prior to use to prevent electrolyte toxicity or local tissue irritation.

Brand names
Potassium Phosphates Injection
Other names
monobasic potassium phosphate and dibasic potassium phosphatepotassium phosphatesmonobasic potassium phosphate + dibasic potassium phosphate

Beyond the preview

Go deeper on potassium phosphate dibasic + potassium phosphate monobasic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on potassium phosphate dibasic + potassium phosphate monobasic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call